Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Results available

Post Approval Study of the Eversense® Continuous Glucose Monitoring

ClinicalTrials.gov ID: NCT03908125

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT03908125. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 19, 2026, 2:54 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Post- Approval Study to Evaluate the Long-term Safety and Effectiveness of the Eversense® Continuous Glucose Monitoring (CGM) System

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Post Approval Study to Evaluate the Long-term Safety and Effectiveness of the Eversense® Continuous Glucose Monitoring (CGM) System over repeat insertion and removal cycles and to demonstrate the long-term safety of the Eversense® CGM System

Study identification

NCT ID
NCT03908125
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
Senseonics, Inc.
Industry
Enrollment
273 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 19, 2019 (Actual)
Primary completion
Feb 1, 2024 (Actual)
Completion
Feb 1, 2024 (Actual)
Last update posted
Jun 12, 2025

2019 – 2024

United States locations

U.S. sites
17
U.S. states
12
U.S. cities
17
Facility City State ZIP Site status
Hoag Memorial Hospital Presbyterian/Mary Dick Allen Diabetes Center Newport Beach California 92663 —
Denver Endocrinology, Diabetes & Thyroid Center Englewood Colorado 80113 —
The Center for Diabetes and Endocrine Care Fort Lauderdale Florida 33312 —
Atlanta Diabetes Associates Atlanta Georgia 30318 —
MODEL Clinical research Baltimore Maryland 21204 —
Metro Detroit Endocrinology Center Dearborn Michigan 48126 —
Diabetes and Endocrinology Specialists, Inc. Chesterfield Missouri 63017 —
Albany Medical College Albany New York 12206 —
Physicians East Greenville North Carolina 27834 —
PMG Research of Wilmington, LLC Wilmington North Carolina 28401 —
Diabetes & Endocrinology Consultants of Pennsylvania, LLC Feasterville Pennsylvania 19053 —
AM Diabetes & Endocrinology Bartlett Tennessee 38133 —
Texas Diabetes and Endocrinology Austin Texas 78731 —
Clinical Research Solution, LLC Cypress Texas 77433 —
Javara, Inc Houston Texas 77095 —
Diabetes and Glandular Disease Clinic San Antonio Texas 78229 —
Consano Clinical Research, LLC Shavano Park Texas 78231 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03908125, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 12, 2025 · Synced Nov 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.